CLSD(Delisted)
Clearside Biomedical (CLSD) Stock Statistics, Valuation & Financial Metrics
Total Valuation
Clearside Biomedical market cap is -- and enterprise value is --.
Share Statistics
Clearside Biomedical has 5.23M shares outstanding, with a free float of 4.17M.
Valuation Ratios
Clearside Biomedical's PE ratio is --, PB ratio is --, and PS ratio is --, showing whether the stock looks expensive or cheap.
Solvency
Clearside Biomedical debt-to-equity ratio is 0 and debt-to-assets ratio is 5.63.
Liquidity
Clearside Biomedical's current ratio is 2.98, quick ratio is 2.98, and cash ratio is 2.46, showing its short-term liquidity position.
Return on Capital
Clearside Biomedical's ROE is --, ROA is -127.43%, and ROIC is --, showing its return on capital profile.
Profitability
Clearside Biomedical gross margin is 88.07%, operating margin is -689.76%, and net margin is -780.90%.
Cost Structure
Clearside Biomedical spends 397.24% of revenue on R&D and 380.59% on SG&A.
Operating Efficiency
Clearside Biomedical's asset turnover is 0.16, inventory turnover is --, and receivables turnover is 6.32, indicating its operating efficiency.
Income Statement
Clearside Biomedical's revenue is 3.33M, gross profit is 2.93M, net income is -26.00M, and EBITDA is -22.68M.
Balance Sheet
Clearside Biomedical's total debt is 0, net debt is 0, total equity is -53.95M, and cash is 6.80M.
Cash Flow Statement
Clearside Biomedical's operating cash flow is -21.29M, free cash flow is -21.75M, and CapEx is -453.00K.
Dividends & Yields
Clearside Biomedical dividend yield is --, with a payout ratio of 0.00% and dividend per share of --.
Analyst Rating
Clearside Biomedical's latest analyst rating is Unrate, with an analyst target price of --.
Company Info
A company developing opthalmic therapeutic products
Per Share Metrics
Clearside Biomedical's EPS is -5.11, book value per share is -10.31, and free cash flow per share is --.
